AI powered screening Onsite Women’s Health leverages a 3D mammography platform enhanced with artificial intelligence and partners with breast-specialized radiologists, presenting a compelling case to healthcare networks seeking advanced imaging capabilities and improved cancer detection rates.

Expansion and partnerships With over 150 locations and ongoing partnerships across multiple practices, there are growth opportunities to expand Mammo with heart programs, integrate AI tools, and broaden in-office breast health services to new markets.

Financial health Reported revenue between $100M and $250M and a leadership cash flow signal via recent executive appointment suggest stability and a runway for channel investments in sales partnerships and technology integrations.

AI integrations Recent integrations with CureMetrix and Therapixel MammoScreen indicate a strategy of embedding AI analytics into screening workflows, offering a clear path for resellers or MSPs to align with Onsite’s technology roadmap.

Digital and partner ecosystem A tech stack that includes HubSpot, WordPress, and Azure, plus multiple practice partnerships, creates opportunities to pitch streamlined partner onboarding, joint marketing programs, and enhanced referral networks to drive new site activations.